Echoing President Donald Trump’s call to accelerate medical innovation, Food and Drug Administration (FDA) Commissioner Marty Makary announced that the agency will no longer block companies from submitting real-world data in drug and device applications. He says the shift will cut costs, reduce delays and open the door to faster cures."One thing we've got to do is deliver on President Trump's goal to give more cures and meaningful treatments to Americans, cutting the red tape, streamlining the FDA, modernizing the organization," Dr. Makary said in an exclusive interview on FOX Business' "Varne...

8 hours ago

On HALO